Literature DB >> 26125152

Meta-analysis of osteoporosis: fracture risks, medication and treatment.

W Liu1, L-H Yang, X-C Kong, L-K An, R Wang.   

Abstract

Osteoporosis is a brittle bone disease that can cause fractures mostly in older men and women. Meta-analysis is the statistical method which is applied in the frame work for the assessment of results obtained from various research studies conducted in several years. A meta-analysis of osteoporotic fracture risk with medication non-adherence has been described to assess the bone fracture risk among patients non-adherent versus adherent to therapy for osteoporosis by many researchers. Osteoporosis therapy reduces the risk of fracture in clinical trials, and real-world adherence to therapy which is suboptimal and can reduce the effectiveness of intervention. The methods of Medline, Embase, and CINAHL were literature searched for these observational studies from year 1998 to 2009, and up to 2015. The results of meta-analysis of osteoporosis research on fractures of postmenopausal women and men are presented. The use of bisphosphonate therapy for osteoporosis has been described with other drugs. The authors, design, studies (women %), years (data), follow-up (wks), fractures (types), and compliance or persistence results from years 2004 to 2009 from are shown in a brief table. The meta-analysis studies have been reviewed from other researchers on osteoporosis and fractures, medications and treatments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26125152

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  8 in total

Review 1.  Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility.

Authors:  Keith L Kirkwood; Lixia Zhang; Ramkumar Thiyagarajan; Kenneth L Seldeen; Bruce R Troen
Journal:  Immunol Invest       Date:  2018-11       Impact factor: 3.657

2.  LncRNA BC083743 Silencing Exacerbated Osteoporosis by Regulating the miR-103-3p/SATB2 Axis to Inhibit Osteogenic Differentiation.

Authors:  Feng Lu; Ling Tang
Journal:  Comput Intell Neurosci       Date:  2022-06-20

3.  Tenuigenin promotes the osteogenic differentiation of bone mesenchymal stem cells in vitro and in vivo.

Authors:  Hua-Ji Jiang; Xing-Gui Tian; Shou-Bin Huang; Guo-Rong Chen; Min-Jun Huang; Yu-Hui Chen; Bin Yan; Sheng-Fa Li; Jia-Jun Tang; Hui-Yu Zhao; Liang Wang; Zhong-Min Zhang
Journal:  Cell Tissue Res       Date:  2016-11-14       Impact factor: 5.249

Review 4.  The roles of bone-derived exosomes and exosomal microRNAs in regulating bone remodelling.

Authors:  Yong Xie; Yanyu Chen; Licheng Zhang; Wei Ge; Peifu Tang
Journal:  J Cell Mol Med       Date:  2016-11-23       Impact factor: 5.310

5.  Celiac disease-related osteopathy among Saudi celiac patients: Are we adherent to recommendations?

Authors:  Mona A Fouda
Journal:  Saudi J Gastroenterol       Date:  2017 Sep-Oct       Impact factor: 2.485

Review 6.  Role of Exosomal Non-Coding RNAs in Bone-Related Diseases.

Authors:  Hang Li; Qiyue Zheng; Xinyan Xie; Jiaojiao Wang; Haihong Zhu; Haoye Hu; Hao He; Qiong Lu
Journal:  Front Cell Dev Biol       Date:  2021-12-23

Review 7.  Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.

Authors:  Jia-Fwu Shyu; Wen-Chih Liu; Cai-Mei Zheng; Te-Chao Fang; Yi-Chou Hou; Chiz-Tzung Chang; Ting-Ying Liao; Yin-Cheng Chen; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

8.  Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis.

Authors:  Jiaqi Wu; Qingsheng Zhang; Guanghui Yan; Xianhui Jin
Journal:  J Orthop Surg Res       Date:  2018-08-02       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.